Financials

  • Market Capitalization 22.43 M
  • Employee 8
  • Founded 2021
  • CEO N/A
  • Website www.allarity.com
  • Headquarter Delaware, United States
  • FIGI BBG012NXCZP8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.59
Relación precio/flujo de caja
-19.81

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4506
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.71 USD+1.43%0.00%+12.70%-74.37%23.62 M USD
4516
ABVC
ABVC BioPharma, Inc. - Common Stock
0.86 USD+3.61%+3.61%-17.31%-69.61%22.92 M USD
4521
COCP
Cocrystal Pharma, Inc. - Common Stock
1.16 USD+5.45%+4.50%+33.33%-25.16%22.35 M USD
4524
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.77 USD+1.40%+3.92%+7.58%+135.38%22.29 M USD

Noticias